PYXS - Pyxis Oncology - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PYXS is currently covered by 8 analysts with an average price target of $8.55. This is a potential upside of $6.97 (441.14%) from yesterday's end of day stock price of $1.58.

Pyxis Oncology's activity chart (see below) currently has 22 price targets and 38 ratings on display. The stock rating distribution of PYXS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 5.07% with an average time for these price targets to be met of 23.38 days.

Highest price target for PYXS is $19, Lowest price target is $7, average price target is $8.55.

Most recent stock forecast was given by LEONID TIMASHEV from RBC on 06-Nov-2026. First documented stock forecast 03-Nov-2021.

Best performing analysts who are covering PYXS - Pyxis Oncology:

Swayampakula Ramakanth Tiago Fauth Eun Yang Tazeen Ahmad Bradley Canino

Currently out of the existing stock ratings of PYXS, 16 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 05-Sep-2023

$7

$5.39 (334.78%)

$5

6 days ago
(06-Nov-2026)

0/8 (0%)

$5.39 (334.78%)

Buy Since 05-May-2026

$7

$5.39 (334.78%)

$8

6 days ago
(06-Nov-2026)

0/3 (0%)

$5.39 (334.78%)

Buy Since 30-Nov-2023

$8

$6.39 (396.89%)

$7

2 months 2 days ago
(10-Sep-2026)

5/14 (35.71%)

$4.73 (144.65%)

187

Buy Since 03-Aug-2026

$19

$17.39 (1080.12%)

$12

2 months 3 days ago
(09-Sep-2026)

0/2 (0%)

$15.62 (462.13%)

Buy Since 23-Jan-2024

$7

$5.39 (334.78%)

$12

4 months 10 days ago
(02-Jul-2026)

0/2 (0%)

$4.37 (166.16%)

Show more analysts

Please expand the browser size to see the chart

What is PYXS (Pyxis Oncology) average time for price targets to be met?

On average it took 23 days for the stock forecasts to be reached, with an average price target met ratio of 5.07%.

Which analyst most recently updated their price target on PYXS (Pyxis Oncology)?

Leonid Timashev

Which analyst has the most public recommendations on PYXS (Pyxis Oncology)?

Leonid Timashev works at RBC and has 18 price targets and 10 ratings on PYXS

Which analyst is the currently most bullish on PYXS (Pyxis Oncology)?

Derek Archila with the highest potential upside of $17.39

Which analyst is the currently most reserved on PYXS (Pyxis Oncology)?

Tiago Fauth with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?